Abstracts tagged "infliximab and prognostic factors"

Abstract Number: 2627 • ACR/ARHP Annual Meeting 2013
Prognostic Factors Of Visual Function In The Treatment With Infliximab For Uveitis Of Behçet’s Disease
Akihiko Nakabayashi¹, Toru Hirano², Yoshihiro Hishitani², Keisuke Hagihara³, Kei Nakai⁴, Kouji Nishida⁴ and Atsushi Kumanogoh², ¹Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, Suita, Japan, ²Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, Suita, Japan, ³Department of Kampo Medicine, Osaka University Graduate School of Medicine, Suita, Japan, ⁴Department of Ophthalmology, Osaka University Graduate School of Medicine, suita, Japan
Background/Purpose: Infliximab, a chimeric monoclonal antibody against TNF-a, is expected to improve prognosis of visual function in patients with severe and refractory uveitis of Behçet's…